A large international study suggests that a subset of people with Type 2 diabetes carry genetic variants that blunt the effectiveness of widely used GLP-1based drugs, despite unexpectedly elevated levels of the hormone in their bodies
Behind the two market leaders are a wave of new entrants hoping to get into the massive market in the coming years
When these criteria apply, mark the request as expedited and document the clinical urgency in the submission
As oral GLP-1 medications become more widely accessible, well integrate them thoughtfully into our programs, always prioritizing what works best for your lifestyle and goals
Clinical trials consistently show that people lose 12 to 18 percent of their body weight when taking these medications along with lifestyle changes
Normalize plateaus and transitions Metabolic adaptation and hormonal shifts make weight plateaus or partial regain after discontinuation expected, not concerning